Product Performance of a New Silicone Hydrogel Contact Lens
Public ClinicalTrials.gov record NCT04901897. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft contact lens wearers on a daily disposable wear basis.
Study identification
- NCT ID
- NCT04901897
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 805 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2019 (Actual)
- Primary completion
- Oct 9, 2019 (Actual)
- Completion
- Oct 9, 2019 (Actual)
- Last update posted
- Jul 8, 2021
2019
United States locations
- U.S. sites
- 35
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 433 | Birmingham | Alabama | 35216 | — |
| Bausch Site 431 | Scottsdale | Arizona | 85254 | — |
| Bausch Site 406 | Azusa | California | 91702 | — |
| Bausch Site 430 | Los Angeles | California | 90013 | — |
| Bausch Site 419 | San Diego | California | 92123 | — |
| Bausch Site 435 | San Francisco | California | 94112 | — |
| Bausch Site 432 | Sunnyvale | California | 94087 | — |
| Bausch Site 409 | Torrance | California | 90503 | — |
| Bausch Site 416 | Denver | Colorado | 80246 | — |
| Bausch Site 415 | Jacksonville | Florida | 32256 | — |
| Bausch Site 434 | Jacksonville | Florida | 32256 | — |
| Bausch Site 405 | Sarasota | Florida | 34237 | — |
| Bausch Site 412 | Decatur | Georgia | 30035 | — |
| Bausch Site 437 | Honolulu | Hawaii | 96814 | — |
| Bausch Site 401 | ‘Aiea | Hawaii | 96701 | — |
| Bausch Site 414 | Leavenworth | Kansas | 66048 | — |
| Bausch Site 413 | Portland | Maine | 04101 | — |
| Bausch Site 421 | Sterling Heights | Michigan | 48312 | — |
| Bausch Site 429 | Edina | Minnesota | 55436 | — |
| Bausch Site 422 | Raytown | Missouri | 64133 | — |
| Bausch Site 407 | St Louis | Missouri | 63144 | — |
| Bausch Site 418 | Warrensburg | Missouri | 64093 | — |
| Bausch Site 424 | Jamestown | New York | 14701 | — |
| Bausch Site 403 | Vestal | New York | 13850 | — |
| Bausch Site 417 | Raleigh | North Carolina | 27603 | — |
| Bausch Site 411 | Fargo | North Dakota | 58103 | — |
| Bausch Site 423 | Miamisburg | Ohio | 45342 | — |
| Bausch Site 425 | West Chester | Ohio | 45069 | — |
| Bausch Site 428 | Grants Pass | Oregon | 97526 | — |
| Bausch Site 420 | State College | Pennsylvania | 16801 | — |
| Bausch Site 427 | Warwick | Rhode Island | 02888 | — |
| Bausch 410 | Brentwood | Tennessee | 37027 | — |
| Bausch Site 408 | Memphis | Tennessee | 33119 | — |
| Bausch Site 404 | Nashville | Tennessee | 37205 | — |
| Bausch Site 426 | League City | Texas | 77573 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04901897, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04901897 live on ClinicalTrials.gov.